BostonSight® announced that Karen Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, has been appointed Chief Innovation and Education Officer. She formerly served as Senior Vice President,...
Alcon has announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment...